☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
AstraZeneca’s Imfinzi (durvalumab) Receives the US FDA’s Approval as the First Immunotherapy Regimen for Advanced Biliary Tract Ca...
September 5, 2022
Spotlight Interview with Rohan (Ro) F. Hastie, President & CEO at Metabolon
September 5, 2022
Sanofi Presents P-III (LIBERTY ASTHMA EXCURSION) trial Results of Dupixent (dupilumab) for Moderate to Severe Asthma at ERS 2022
September 5, 2022
Astellas Reports P-III (MOONLIGHT 3) Trial Results of Fezolinetant for the Treatment of Vasomotor Symptoms Associated with Menopau...
September 5, 2022
BMS’ Azacitidine Receives NICE Recommendation for the Treatment of Acute Myeloid Leukaemia
September 5, 2022
Gilead Reports P-III (TROPiCS-02) Study Results of Trodelvy (sacituzumab govitecan-hziy) for HR+/HER2- Metastatic Breast Cancer
September 5, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions